The hematopoietic stem cells found in cord blood differ from other cells in the body, which typically can only generate copies of themselves, when the patient is suffering from any ailments, which is one of the benefits of cord blood banking services. These potent stem cells, which are also present in bone marrow, can differentiate into several blood and immune system cell types. Over 70 different diseases are treated with stem cells, including neurological problems, cancer, immune system disorders, and genetic disorders.
Frequently Asked Questions
The market is segmented based on Global Cord Blood and Cell Banking Market Segmentation, By Type of Bank (Public, Private), Services (Processing, Storage), Application (Cancer, Blood Disorders, Immuno-deficiency Disorders, Metabolic Disorders, Bone Marrow Failure Syndrome), End-Use (Hospitals, Research Institutes, Specialty Clinics) – Industry Trends and Forecast to 2032.
.
The Global Cord Blood And Cell Banking Market size was valued at USD 2.16 USD Billion in 2024.
The Global Cord Blood And Cell Banking Market is projected to grow at a CAGR of 12.92% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
